Abstract
The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.
Author supplied keywords
Cite
CITATION STYLE
APA
Dong, H. P., Yang, R. C., Chunag, I. C., Huang, L. J., Li, H. T., Chen, H. L., & Chen, C. Y. (2012). Inhibitory effect of hexahydrocurcumin on human platelet aggregation. Natural Product Communications, 7(7), 883–884. https://doi.org/10.1177/1934578x1200700719
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free